Tara Thigpen

Tara Thigpen

Goodwin

Contact
View Bio
RSS

Latest Posts › Celltrion

Share:

FDA Approves Celltrion’s OMLYCLO® (omalizumab-igec)

On March 9, 2025, Celltrion announced that the FDA has approved OMLYCLO® (omalizumab-igec), the first and only biosimilar of XOLAIR® (omalizumab)....more

3/19/2025  /  Biosimilars , Celltrion , FDA Approval , Food and Drug Administration (FDA) , Pharmaceutical Industry , Prescription Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide